Business News

Haleon Invests in India to Bring Better Everyday Life to Rural Communities

Article content

How much is Haleon investing in India, and how will this investment be completed?

Article content

Haleon is investing approximately £175 million in capital expenditure in a new oral health manufacturing facility in Madhya Pradesh. This investment will be made in phases over the period 2025 – 2029. The site is expected to open in early 2028, and supply will begin the following year, supporting the company’s long-term growth plans in India. The investment is in line with Haleon’s capital allocation priorities as outlined in the company’s Capital Markets Day 2025.

Article content

How will this investment support Haleon’s growth strategy?

Article content

The investment supports Haleon’s Victory as a Single strategy by strengthening internal supply chain capabilities and enabling faster response to customer needs. It is also part of Haleon’s ‘Build for the Future’ initiative, which is transforming Haleon’s global supply chain to meet long-term needs, including investments in key growth markets such as India and China.

Article content

Will the new manufacturing site support exports to other markets?

Article content

The new site is focused on meeting growing demand within India, one of our fastest growing markets, while serving other parts of Asia. The site strengthens local manufacturing capacity and supply chain sustainability, becoming part of our broader global supply chain transformation.

Article content

How does this investment strengthen Haleon’s presence in India?

Article content

We invest in markets where we see opportunities to innovate and create value. This investment strengthens Haleon’s capabilities in India by expanding domestic production and building a strong, local supply network closer to consumers. It improves agility to meet growing demand – particularly in underserved and rural communities – while supporting the company’s broader efforts to improve and transform its global supply chain.

Article content

How many people does Haleon employ in India, and will this investment create jobs?

Article content

Haleon already employs a significant workforce across India. The new manufacturing facility will create 500 jobs and strengthen local skills. In addition, the company has hired more than 500 people to its sales teams in the past 12 months to support expanded distribution.

Article content

How does this announcement build on Haleon’s presence in India?

Article content

Since going private in 2022, Haleon has redefined its presence in India – building its own dedicated sales and distribution network. This investment builds on that foundation, strengthening access to market and accelerating rural access to reach more underserved communities.

Article content

Article content

Why did you choose Madhya Pradesh as the location for the new site?

Article content

Madhya Pradesh is ideally placed in the heart of the country and the chosen site because of its proximity to infrastructure, higher education, transport, talent and incentives.

Article content

Where does India sit within Haleon’s global operating model?

Article content

Haleon’s new operating model – announced earlier this year – established the Indian Subcontinent as a separate Operations Unit, reporting directly to the CEO, reflecting the level and potential of market growth and emphasizing the strategic importance of these investments.

Article content

About Haleon

Article content

Haleon (LSE/NYSE: HLN) is a consumer company focused solely on a better everyday life. Our people, our brands, our research, our investments and our innovation are aimed at improving the everyday lives of consumers. Our product portfolio includes six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and more. Our superior products – such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu again Voltaren – trusted by over one billion consumers and recommended by health professionals around the world.

Article content

For more information, please visit www.haleon.com

Article content

Article content

Article content

View the source version on businesswire.com:

Article content

https://www.businesswire.com/news/home/20260608753094/en/

Article content

a symbol

Article content

Article content

Philippa Keir – philippa.l.keir@haleon.com – +447969271455
Victoria Durman – victoria.a.durman@haleon.com – +447894505730

Article content

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button